1 |
Wang N, Pan D, Wang X, Su M, Wang X, Yan Q, Sun G, Wang S. NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients 2022;14. [PMID: 36432602 DOI: 10.3390/nu14224916] [Reference Citation Analysis]
|
2 |
Thakur N, Yim K, Abdul-Ghafar J, Seo KJ, Chong Y. High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:5594. [PMID: 34830749 DOI: 10.3390/cancers13225594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Wang Y, Xia XB, Tang HZ, Cai JR, Shi XK, Ji HX, Yan XN, Xu T. Association of T2285C polymorphism in PARP1 gene coding region with its expression, activity and NSCLC risk along with prognosis. Mutagenesis 2021:geab022. [PMID: 34132814 DOI: 10.1093/mutage/geab022] [Reference Citation Analysis]
|
4 |
Xin Y, Yang L, Su M, Cheng X, Zhu L, Liu J. PARP1 rs1136410 Val762Ala contributes to an increased risk of overall cancer in the East Asian population: a meta-analysis. J Int Med Res 2021;49:300060521992956. [PMID: 33706586 DOI: 10.1177/0300060521992956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Saitoh T, Oda T. DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment. Cancers (Basel) 2021;13:504. [PMID: 33525741 DOI: 10.3390/cancers13030504] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
6 |
Li H, Zha Y, Du F, Liu J, Li X, Zhao X. Contributions of PARP-1 rs1136410 C>T polymorphism to the development of cancer. J Cell Mol Med 2020;24:14639-44. [PMID: 33108038 DOI: 10.1111/jcmm.16027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Liao Y, Liao Y, Li J, Xiong J, Fan Y. Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy. Sci Rep 2020;10:7349. [PMID: 32355298 DOI: 10.1038/s41598-020-64473-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
8 |
Gotoh N, Minato Y, Saitoh T, Takahashi N, Kasamatsu T, Souma K, Oda T, Hoshino T, Sakura T, Ishizaki T, Shimizu H, Takizawa M, Yokohama A, Tsukamoto N, Handa H, Murakami H. PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes. Eur J Haematol 2020;104:526-37. [PMID: 32003046 DOI: 10.1111/ejh.13393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
9 |
Khan AU, Mahjabeen I, Malik MA, Hussain MZ, Khan S, Kayani MA. Modulation of brain tumor risk by genetic SNPs in PARP1gene: Hospital based case control study. PLoS One 2019;14:e0223882. [PMID: 31609976 DOI: 10.1371/journal.pone.0223882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
10 |
Sharma N, Saxena S, Agrawal I, Singh S, Srinivasan V, Arvind S, Epari S, Paul S, Jha S. Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma. Sci Rep 2019;9:8480. [PMID: 31186453 DOI: 10.1038/s41598-019-44854-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
11 |
Zanussi S, Casarotto M, Pratesi C, Paoli PD. Gastric Tumorigenesis: Role of Inflammation and Helicobacter pylori. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
12 |
Bashir K, Sarwar R, Saeed S, Mahjabeen I, Kayani MA. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma. PLoS One 2018;13:e0199007. [PMID: 30183716 DOI: 10.1371/journal.pone.0199007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
13 |
De Mello RA, Castelo-branco L, Castelo-branco P, Pozza DH, Vermeulen L, Palacio S, Salzberg M, Lockhart AC. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies? American Society of Clinical Oncology Educational Book 2018. [DOI: 10.1200/edbk_198805] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
14 |
Azevedo AP, Silva SN, De Lima JP, Reichert A, Lima F, Júnior E, Rueff J. DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms. Oncol Lett 2017;13:4641-50. [PMID: 28599464 DOI: 10.3892/ol.2017.6065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
15 |
Rank L, Veith S, Gwosch EC, Demgenski J, Ganz M, Jongmans MC, Vogel C, Fischbach A, Buerger S, Fischer JM, Zubel T, Stier A, Renner C, Schmalz M, Beneke S, Groettrup M, Kuiper RP, Bürkle A, Ferrando-May E, Mangerich A. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res 2016;44:10386-405. [PMID: 27694308 DOI: 10.1093/nar/gkw859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
16 |
Köberle B, Koch B, Fischer BM, Hartwig A. Single nucleotide polymorphisms in DNA repair genes and putative cancer risk. Arch Toxicol 2016;90:2369-88. [PMID: 27334373 DOI: 10.1007/s00204-016-1771-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
|
17 |
Jia ZF, Zhang SL, Cao XY, Zhou BS, Jiang J. Interaction between Helicobacter pylori and host genetic variants in gastric carcinogenesis. Future Oncol. 2016;12:2127-2134. [PMID: 27324311 DOI: 10.2217/fon-2016-0233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
18 |
Larionov AV, Sinitsky MY, Druzhinin VG, Volobaev VP, Minina VI, Asanov MA, Meyer AV, Tolochko TA, Kalyuzhnaya EE. DNA excision repair and double-strand break repair gene polymorphisms and the level of chromosome aberration in children with long-term exposure to radon. International Journal of Radiation Biology 2016;92:466-74. [DOI: 10.1080/09553002.2016.1186303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
19 |
Kotsopoulos IC, Kucukmetin A, Mukhopadhyay A, Lunec J, Curtin NJ. Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis: Mechanism and Potential Role for PARP Inhibitors. Int J Gynecol Cancer 2016;26:763-9. [DOI: 10.1097/igc.0000000000000654] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
20 |
Veith S, Mangerich A. RecQ helicases and PARP1 team up in maintaining genome integrity. Ageing Res Rev 2015;23:12-28. [PMID: 25555679 DOI: 10.1016/j.arr.2014.12.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
|
21 |
Sistigu A, Manic G, Obrist F, Vitale I. Trial watch - inhibiting PARP enzymes for anticancer therapy. Mol Cell Oncol 2016;3:e1053594. [PMID: 27308587 DOI: 10.1080/23723556.2015.1053594] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|